Position in HIMS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$21,097,007
+$12,416,965 QoQ
Shares Held
608,509
+127.6% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#39
of 504 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EMERALD ADVISERS, LLC holds $22,866,585 across 5 Drug Manufacturers - Specialty & Generic names. HIMS ranks #1 (92.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
This page
|
608,509 | $21,097,007 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,548 | $831,686 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,469 | $795,948 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
1,256 | $103,971 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
1,049 | $37,973 |
All Filings in HIMS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,097,007 | 608,509 | Shares | Sole | 2026-08-05 | |
| 2025-12-31 | $8,680,042 | 267,325 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $17,351,839 | 305,921 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||